BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 15288476)

  • 21. Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells.
    Hung CM; Kuo DH; Chou CH; Su YC; Ho CT; Way TD
    J Agric Food Chem; 2011 Sep; 59(17):9683-90. PubMed ID: 21806057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.
    Monga SP; Mars WM; Pediaditakis P; Bell A; Mulé K; Bowen WC; Wang X; Zarnegar R; Michalopoulos GK
    Cancer Res; 2002 Apr; 62(7):2064-71. PubMed ID: 11929826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
    Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
    Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
    Halaban R; Rubin JS; Funasaka Y; Cobb M; Boulton T; Faletto D; Rosen E; Chan A; Yoko K; White W
    Oncogene; 1992 Nov; 7(11):2195-206. PubMed ID: 1331934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the met receptor in mesothelioma.
    Mukohara T; Civiello G; Davis IJ; Taffaro ML; Christensen J; Fisher DE; Johnson BE; Jänne PA
    Clin Cancer Res; 2005 Nov; 11(22):8122-30. PubMed ID: 16299245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
    Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
    Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells.
    De Lédinghen V; Monvoisin A; Neaud V; Krisa S; Payrastre B; Bedin C; Desmoulière A; Bioulac-Sage P; Rosenbaum J
    Int J Oncol; 2001 Jul; 19(1):83-8. PubMed ID: 11408926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor protects hepatoma cells against oxidative stress-induced cell death.
    Osada S; Imai H; Tomita H; Tokuyma Y; Okumura N; Sakashita F; Nonoka K; Sugiyama Y
    J Gastroenterol Hepatol; 2006 Jun; 21(6):988-93. PubMed ID: 16724983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor.
    Pan BS; Chan GK; Chenard M; Chi A; Davis LJ; Deshmukh SV; Gibbs JB; Gil S; Hang G; Hatch H; Jewell JP; Kariv I; Katz JD; Kunii K; Lu W; Lutterbach BA; Paweletz CP; Qu X; Reilly JF; Szewczak AA; Zeng Q; Kohl NE; Dinsmore CJ
    Cancer Res; 2010 Feb; 70(4):1524-33. PubMed ID: 20145145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1.
    Jiang Y; Xu W; Lu J; He F; Yang X
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1123-30. PubMed ID: 11527416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2.
    Hu CT; Cheng CC; Pan SM; Wu JR; Wu WS
    Cell Signal; 2013 Jun; 25(6):1457-67. PubMed ID: 23524339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
    Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model.
    Boost KA; Kim HJ; Engl T; Oppermann E; Jonas D; Oertl A; Blaheta RA
    Int J Mol Med; 2006 Mar; 17(3):475-82. PubMed ID: 16465395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of tumor-stromal interaction through HGF/Met signaling by valproic acid.
    Matsumoto Y; Motoki T; Kubota S; Takigawa M; Tsubouchi H; Gohda E
    Biochem Biophys Res Commun; 2008 Feb; 366(1):110-6. PubMed ID: 18053801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma.
    Coltella N; Manara MC; Cerisano V; Trusolino L; Di Renzo MF; Scotlandi K; Ferracini R
    FASEB J; 2003 Jun; 17(9):1162-4. PubMed ID: 12709413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
    Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
    J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.